Mesothelioma, Malignant

Overview

A type of mesothelioma with a tendency to metastasize. Most tumors originate from either the PLEURA or PERITONEUM, tumors may also originate in the PERICARDIUM or testicular tissue. It is associated with ASBESTOS exposure. Somatic mutations identified in WT1, BCL10, CDKN2A, NF2, and BAP1 genes are associated with the malignancy. OMIM: 156240.

This information is general and should not be treated as medical advice. Always speak directly with a qualified healthcare professional before making decisions about treatment, diagnosis, procedures, medicines or care.

Quick facts about Mesothelioma, Malignant

Topic type

Condition

Category

Oncology

MeSH classification

C04.557.470.035.510.757|C04.557.470.660.510.757|C04.588.894.797.520.173|C04.588.894.797.640.350|C08.381.540.144|C08.785.520.124|C08.785.640.350

Preparing for an appointment about Mesothelioma, Malignant

If you are speaking with a healthcare professional about Mesothelioma, Malignant, it can help to prepare a few details in advance.

• Write down your symptoms and when they started.
• Bring details of any medicines, supplements or previous treatments.
• Ask what tests or assessments may be needed.
• Ask what treatment or management options may be suitable.
• Ask when you should seek urgent medical help or follow-up care.

Finding care related to Mesothelioma, Malignant

EuroCareFinder helps patients explore clinics and healthcare providers across Europe. Some topics link directly to services offered by clinics, while others may be connected through related specialties, treatments or procedures.

Related topics

Explore healthcare providers

Use EuroCareFinder to browse clinics by country, specialty and available services.